Controlled Drug Release from Nanoengineered Polysaccharides
Pharmaceutics · 28.04.2023 · 15 (5) · 1364
DOI: 10.3390/pharmaceutics15051364 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 28.04.2023. Verfasst von Ilker S Bayer. Beteiligte Einrichtung: Smart Materials, Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy. Die Arbeit wurde bisher 234-mal zitiert (Crossref) und nennt 237 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Polysaccharides are naturally occurring complex molecules with exceptional physicochemical properties and bioactivities. They originate from plant, animal, and microbial-based resources and processes and can be chemically modified. The biocompatibility and biodegradability of polysaccharides enable their increased use in nanoscale synthesis and engineering for drug encapsulation and release. This review focuses on sustained drug release studies from nanoscale polysaccharides in the fields of nanotechnology and biomedical sciences. Particular emphasis is placed on drug release kinetics and relevant mathematical models. An effective release model can be used to envision the behavior of specific nanoscale polysaccharide matrices and reduce impending experimental trial and error, saving time and resources. A robust model can also assist in translating from in vitro to in vivo experiments. The main aim of this review is to demonstrate that any study that establishes sustained release from nanoscale polysaccharide matrices should be accompanied by a detailed analysis of drug release kinetics by modeling since sustained release from polysaccharides not only involves diffusion and degradation but also surface erosion, complicated swelling dynamics, crosslinking, and drug-polymer interactions. As such, in the first part, we discuss the classification and role of polysaccharides in various applications and later elaborate on the specific pharmaceutical processes of polysaccharides in ionic gelling, stabilization, cross-linking, grafting, and encapsulation of drugs. We also document several drug release models applied to nanoscale hydrogels, nanofibers, and nanoparticles of polysaccharides and conclude that, at times, more than one model can accurately describe the sustained release profiles, indicating the existence of release mechanisms running in parallel. Finally, we conclude with the future opportunities and advanced applications of nanoengineered polysaccharides and their theranostic aptitudes for future clinical applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Smart Materials, Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy.
ORCID-Profile: Ilker S Bayer
Zitieren
APA
Bayer, I. S. (2023). Controlled Drug Release from Nanoengineered Polysaccharides. Pharmaceutics, 15(5), 1364. https://doi.org/10.3390/pharmaceutics15051364
Vancouver
Bayer IS. Controlled Drug Release from Nanoengineered Polysaccharides. Pharmaceutics. 2023;15(5):1364. doi:10.3390/pharmaceutics15051364
BibTeX
@article{Bayer2023,
author = {Bayer, Ilker S},
title = {Controlled Drug Release from Nanoengineered Polysaccharides},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {5},
pages = {1364},
doi = {10.3390/pharmaceutics15051364}
}
EUVIMED